I am looking forward to our first in-person events of 2022 this week, headlined by the BIA’s Annual Gala Dinner. This is a chance to celebrate the fantastic work undertaken by the sector throughout 2021 and raise money for our Charity Partner of the Year, Kidney Research UK. There are a few individual tickets left, so do book quickly if you are interested in attending.
Dr Ruth McKernan CBE, former chair of the BioIndustry Association and former Chair of Innovate UK, discusses the future of antivirals in relation to COVID-19 and how this works with current government processes.
The UK sector was out in virtual force at the annual JP Morgan Healthcare conference held virtually last week. It was great to see UK companies at the forefront of the global themes. I’m really looking forward to seeing many of you on 27 January as we gather in person to celebrate the achievements of the sector at the BIA Gala Dinner. I’m glad to confirm that Science Minister George Freeman MP will be our pre dinner keynote speaker.
Love Your Liver is a national awareness month devoted to liver health awareness and giving people the key steps needed to keep their liver healthy.
We spoke to Ochre Bio, a liver medicines company, to find out what they're up to in this space.
Welcome to the first CEO blog of 2022, one I’m delighted not to have penned from an overpriced hotel room in San Francisco – my normal place of work this time of year. A new year normally means a fresh start, but it seems the year will again be dominated by how governments and global economies will respond to the COVID-19 pandemic.
Best wishes of the season from everyone at BIA. It has been fantastic working with you in 2021 and we would like to take this opportunity to thank you for your support throughout the year.
For those following the implications of the Northern Ireland Protocol discussions with regard to medicines, more information here.
Read the blog by Ian Campbell, Chief Business Officer, Life Arc, who was asked by the Scottish Government to look at how health innovation life science and healthtech ecosystem can attract increased levels of private investment.
In this blog, Ovarian Cancer Action shares their thoughts on the Charity of the Year partnership. The partnership has not only helped to raise money towards vital research to help more women survive ovarian cancer, but has opened doors to maximise the impact of OCA's research over the next five years.
Following the Annual General Meeting (AGM) in October, we'd like to announce the next Chair and members who have been elected to the BIA Board of Directors. We also would like to welcome our new marketing function and three new starters in the Policy and Public Affairs team. Find out more about them and the winner of the Knowledge Transfer Network lifetime achievement award.
I’m looking forward to participating in our joint MHRA and BIA regulatory conference virtually this Wednesday, it’s a fantastic agenda hearing more about how we can transform regulation, drive innovation and ultimately enable safe patient access. Also, read about Biotech’s day on the Government grid, financing news and two great TV programmes to watch this week.